A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.
Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
A Randomized, Double Blind, Placebo Controlled, Phase 2 Dose Escalation Study to Investigate
the Safety and Pharmacokinetics after Single and Multiple I.V. Doses of SLV334 in Sequential
Cohorts of Patients with Moderate and Severe Traumatic Brain Injury.